An Analysis of Bibliometric Research on Sumatriptan (Imitrex, Tosymra) Linked to Migraine Relief

Abstract

Episodic headaches are a common neurovascular disorder called migraine characterized by a throbbing pain that is typically felt on one side of the brain, however it can occasionally affect both sides. However, no visual bibliometric analysis has been conducted on the effects of sumatriptan on migraine over the past 10 years. Objective: To identify the current status and emerging trends of the global use of sumatriptan associated with the relief of migraine from 2011 to 2022. Methods: Approximately 3154 publications (500 from PubMed and 2654 from dimensions) in CSV format were exported from PubMed and dimensions to VOS viewer. The keywords applied for searching were “sumatriptan” and “sumatriptan in migraine”. Results: The results of bibliometric analysis of the occurrence of keywords by VOS viewer revealed the top four most occurring keywords as “effect”, “relief”, “model”, and “mechanism”. The bibliometric analysis for the graphical distribution of a maximum number of articles by countries in 2011-2022 reveals Germany, the US, and Australia as the top three countries. The analysis for a maximum number of publications by organizations in 2011-2022 showed the top three organizations with a maximum number of articles are “Headache Core Center, Springfield, USA”, “Montefiore Medical Center, USA”, and “Experimental Medicine Research Center, Tehran University”. Conclusions: The compiled data of this exploration will make it easier for other academic research work to find authentic and fruitful results for complex future studies.